Cargando…

Biotransformation of artemisinin to a novel derivative via ring rearrangement by Aspergillus niger

ABSTRACT: Artemisinin is a component part of current frontline medicines for the treatment of malaria. The aim of this study is to make analogues of artemisinin using microbial transformation and evaluate their in vitro antimalarial activity. A panel of microorganisms were screened for biotransforma...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Jiaer, Mobley, Rebecca, Woodfine, Sian, Drijfhout, Falko, Horrocks, Paul, Ren, Xiao-Dong, Li, Wen-Wu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989930/
https://www.ncbi.nlm.nih.gov/pubmed/35355096
http://dx.doi.org/10.1007/s00253-022-11888-0
_version_ 1784683278676000768
author Luo, Jiaer
Mobley, Rebecca
Woodfine, Sian
Drijfhout, Falko
Horrocks, Paul
Ren, Xiao-Dong
Li, Wen-Wu
author_facet Luo, Jiaer
Mobley, Rebecca
Woodfine, Sian
Drijfhout, Falko
Horrocks, Paul
Ren, Xiao-Dong
Li, Wen-Wu
author_sort Luo, Jiaer
collection PubMed
description ABSTRACT: Artemisinin is a component part of current frontline medicines for the treatment of malaria. The aim of this study is to make analogues of artemisinin using microbial transformation and evaluate their in vitro antimalarial activity. A panel of microorganisms were screened for biotransformation of artemisinin (1). The biotransformation products were extracted, purified and isolated using silica gel column chromatography and semi-preparative HPLC. Spectroscopic methods including LC-HRMS, GC–MS, FT-IR, 1D and 2D NMR were used to elucidate the structure of the artemisinin metabolites.(1)H NMR spectroscopy was further used to study the time-course biotransformation. The antiplasmodial activity (IC(50)) of the biotransformation products of 1 against intraerythrocytic cultures of Plasmodium falciparum were determined using bioluminescence assays. A filamentous fungus Aspergillus niger CICC 2487 was found to possess the best efficiency to convert artemisinin (1) to a novel derivative, 4-methoxy-9,10-dimethyloctahydrofuro-(3,2-i)-isochromen-11(4H)-one (2) via ring rearrangement and further degradation, along with three known derivatives, compound (3), deoxyartemisinin (4) and 3-hydroxy-deoxyartemisinin (5). Kinetic study of the biotransformation of artemisinin indicated the formation of artemisinin G as a key intermediate which could be hydrolyzed and methylated to form the new compound 2. Our study shows that the anti-plasmodial potency of compounds 2, 3, 4 and 5 were ablated compared to 1, which attributed to the loss of the unique peroxide bridge in artemisinin (1). This is the first report of microbial degradation and ring rearrangement of artemisinin with subsequent hydrolysis and methoxylation by A.niger. KEY POINTS: • Aspergillus niger CICC 2487 was found to be efficient for biotransformation of artemisinin • A novel and unusual artemisinin derivative was isolated and elucidated • The peroxide bridge in artemisinin is crucial for its high antimalarial potency • The pathway of biotransformation involves the formation of artemisinin G as a key intermediate SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00253-022-11888-0.
format Online
Article
Text
id pubmed-8989930
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-89899302022-04-22 Biotransformation of artemisinin to a novel derivative via ring rearrangement by Aspergillus niger Luo, Jiaer Mobley, Rebecca Woodfine, Sian Drijfhout, Falko Horrocks, Paul Ren, Xiao-Dong Li, Wen-Wu Appl Microbiol Biotechnol Biotechnological Products and Process Engineering ABSTRACT: Artemisinin is a component part of current frontline medicines for the treatment of malaria. The aim of this study is to make analogues of artemisinin using microbial transformation and evaluate their in vitro antimalarial activity. A panel of microorganisms were screened for biotransformation of artemisinin (1). The biotransformation products were extracted, purified and isolated using silica gel column chromatography and semi-preparative HPLC. Spectroscopic methods including LC-HRMS, GC–MS, FT-IR, 1D and 2D NMR were used to elucidate the structure of the artemisinin metabolites.(1)H NMR spectroscopy was further used to study the time-course biotransformation. The antiplasmodial activity (IC(50)) of the biotransformation products of 1 against intraerythrocytic cultures of Plasmodium falciparum were determined using bioluminescence assays. A filamentous fungus Aspergillus niger CICC 2487 was found to possess the best efficiency to convert artemisinin (1) to a novel derivative, 4-methoxy-9,10-dimethyloctahydrofuro-(3,2-i)-isochromen-11(4H)-one (2) via ring rearrangement and further degradation, along with three known derivatives, compound (3), deoxyartemisinin (4) and 3-hydroxy-deoxyartemisinin (5). Kinetic study of the biotransformation of artemisinin indicated the formation of artemisinin G as a key intermediate which could be hydrolyzed and methylated to form the new compound 2. Our study shows that the anti-plasmodial potency of compounds 2, 3, 4 and 5 were ablated compared to 1, which attributed to the loss of the unique peroxide bridge in artemisinin (1). This is the first report of microbial degradation and ring rearrangement of artemisinin with subsequent hydrolysis and methoxylation by A.niger. KEY POINTS: • Aspergillus niger CICC 2487 was found to be efficient for biotransformation of artemisinin • A novel and unusual artemisinin derivative was isolated and elucidated • The peroxide bridge in artemisinin is crucial for its high antimalarial potency • The pathway of biotransformation involves the formation of artemisinin G as a key intermediate SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00253-022-11888-0. Springer Berlin Heidelberg 2022-03-31 2022 /pmc/articles/PMC8989930/ /pubmed/35355096 http://dx.doi.org/10.1007/s00253-022-11888-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Biotechnological Products and Process Engineering
Luo, Jiaer
Mobley, Rebecca
Woodfine, Sian
Drijfhout, Falko
Horrocks, Paul
Ren, Xiao-Dong
Li, Wen-Wu
Biotransformation of artemisinin to a novel derivative via ring rearrangement by Aspergillus niger
title Biotransformation of artemisinin to a novel derivative via ring rearrangement by Aspergillus niger
title_full Biotransformation of artemisinin to a novel derivative via ring rearrangement by Aspergillus niger
title_fullStr Biotransformation of artemisinin to a novel derivative via ring rearrangement by Aspergillus niger
title_full_unstemmed Biotransformation of artemisinin to a novel derivative via ring rearrangement by Aspergillus niger
title_short Biotransformation of artemisinin to a novel derivative via ring rearrangement by Aspergillus niger
title_sort biotransformation of artemisinin to a novel derivative via ring rearrangement by aspergillus niger
topic Biotechnological Products and Process Engineering
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989930/
https://www.ncbi.nlm.nih.gov/pubmed/35355096
http://dx.doi.org/10.1007/s00253-022-11888-0
work_keys_str_mv AT luojiaer biotransformationofartemisinintoanovelderivativeviaringrearrangementbyaspergillusniger
AT mobleyrebecca biotransformationofartemisinintoanovelderivativeviaringrearrangementbyaspergillusniger
AT woodfinesian biotransformationofartemisinintoanovelderivativeviaringrearrangementbyaspergillusniger
AT drijfhoutfalko biotransformationofartemisinintoanovelderivativeviaringrearrangementbyaspergillusniger
AT horrockspaul biotransformationofartemisinintoanovelderivativeviaringrearrangementbyaspergillusniger
AT renxiaodong biotransformationofartemisinintoanovelderivativeviaringrearrangementbyaspergillusniger
AT liwenwu biotransformationofartemisinintoanovelderivativeviaringrearrangementbyaspergillusniger